These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20695368)

  • 1. [Anticholinergics and their cardiovascular effects--between fear and reality].
    Mihălţan F; Ulmeanu R
    Pneumologia; 2010; 59(2):107-8. PubMed ID: 20695368
    [No Abstract]   [Full Text] [Related]  

  • 2. How safe are anticholinergics in patients with COPD?
    Hew MJ; Sestini P; Irving LB
    Med J Aust; 2009 May; 190(9):468-9. PubMed ID: 19413514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Postgrad Med J; 2014 Apr; 90(1062):205-7. PubMed ID: 24643260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic treatment in airways diseases.
    Flynn RA; Glynn DA; Kennedy MP
    Adv Ther; 2009 Oct; 26(10):908-19. PubMed ID: 19967500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular risk of tiotropium: is it real?
    Cazzola M; Calzetta L; Matera MG
    Expert Opin Drug Saf; 2010 Sep; 9(5):783-92. PubMed ID: 20565229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
    Nagy LB
    Orv Hetil; 2015 Aug; 156(31):1246-52. PubMed ID: 26211748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Thorax; 2013 Jan; 68(1):114-6. PubMed ID: 22764216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
    Singh S; Furberg CD
    Arch Intern Med; 2011 May; 171(10):920-2. PubMed ID: 21606097
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA
    Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of ipratropium bromide.
    Kumar Singh S
    Chest; 2010 Jul; 138(1):235; author reply 235-6. PubMed ID: 20605831
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tiotropium bromide in the treatment of chronic obstructive lung disease].
    Shmelev EI
    Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476
    [No Abstract]   [Full Text] [Related]  

  • 13. Tiotropium and chronic obstructive pulmonary disease.
    McIvor RA
    BMJ; 2010 Feb; 340():c833. PubMed ID: 20172927
    [No Abstract]   [Full Text] [Related]  

  • 14. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR
    Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiriva (Respimat) increases mortality by 52% in patients with COPD: time to take action.
    Ram FS
    N Z Med J; 2011 Jun; 124(1337):117-8. PubMed ID: 21946887
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
    BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photosensitive lichenoid eruption and inhaled tiotropium bromide.
    Pérez-Pérez L; Cabanillas M; Pereiro Ferreirós MM; Peteiro C; Toribio J
    Dermatology; 2007; 214(1):97-8. PubMed ID: 17191057
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    Hodgin KE; Maloney JP
    JAMA; 2009 Mar; 301(12):1224; author reply 1225-6. PubMed ID: 19318647
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
    Rochat T; Janssens JP
    Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.